The ability of all four cardiac hormones to markedly decrease leptin levels was suggestive of a novel potential treatment target for hypertension in obesity, since these four cardiac hormones have demonstrated blood pressure-lowering properties (21–29). Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.